Evaluation of intravenous amoxicillin-clavulanate use in two Canadian hospitals

We describe our experience with intravenous amoxicillin-clavulanate, which is new to the Canadian market. The majority of patients were successfully de-escalated from piperacillin-tazobactam or a carbapenem for respiratory infections or skin and soft tissue infections. Intravenous amoxicillin-clavul...

Full description

Bibliographic Details
Main Authors: Maggie Wong, Sangita Malhotra, Kevin Afra
Format: Article
Language:English
Published: Cambridge University Press 2024-01-01
Series:Antimicrobial Stewardship & Healthcare Epidemiology
Online Access:https://www.cambridge.org/core/product/identifier/S2732494X24000184/type/journal_article